The Impact Of Diabetes Mellitus And Microvascular Complications On Heart Failure Biomarkers
•HF-biomarkers used in the general population are also suitable in patients with DM•sST2 levels are significantly correlated with NT-proBNP and hypocholesterolemia•Gal-3 sees the highest levels in subjects with DM and microvascular complications
Gespeichert in:
| Veröffentlicht in: | European journal of internal medicine 2020-08, Vol.78, p.157-158 |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 158 |
|---|---|
| container_issue | |
| container_start_page | 157 |
| container_title | European journal of internal medicine |
| container_volume | 78 |
| creator | Frîngu, Florina Zdrenghea, Dumitru Tomoaia, Raluca Dădârlat-Pop, Alexandra Pop, Dana |
| description | •HF-biomarkers used in the general population are also suitable in patients with DM•sST2 levels are significantly correlated with NT-proBNP and hypocholesterolemia•Gal-3 sees the highest levels in subjects with DM and microvascular complications |
| doi_str_mv | 10.1016/j.ejim.2020.04.025 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2392467249</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0953620520301394</els_id><sourcerecordid>2392467249</sourcerecordid><originalsourceid>FETCH-LOGICAL-c307t-8786977465ebb2b28a0c967d7fdba140509f9a767f81226ec6e396a6a2ad02183</originalsourceid><addsrcrecordid>eNp9kEtP3DAUha2qVZlS_kAXlZfdJL2-SfyQ2MAABQk0G7piYTnOjeppHoOdjMS_J6OBLru6m-8c3fMx9k1ALkDIn9uctqHPERByKHPA6gNbCa1MBhr1R7YCUxWZRKhO2JeUtgBCARSf2UmBBVSo9Yo9Pf4hftfvnJ_4puVXwdU0UeIP1HVhmhO_GBr-EHwc9y75uXORr8d-1wXvpjAOiW8GfksuTvzGhW6OxC_D2Lv4l2L6yj61rkt09nZP2e-b68f1bXa_-XW3vrjPfAFqyrTS0ihVyorqGmvUDryRqlFtUztRQgWmNU5J1WqBKMlLKox00qFrAIUuTtmPY-8ujs8zpcn2IfllgBtonJPFwmApFZZmQfGILoNSitTaXQzLuy9WgD1ItVt7kGoPUi2UdpG6hL6_9c91T82_yLvFBTg_ArSs3AeKNvlAg6cmRPKTbcbwv_5Xse2Hdw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2392467249</pqid></control><display><type>article</type><title>The Impact Of Diabetes Mellitus And Microvascular Complications On Heart Failure Biomarkers</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Frîngu, Florina ; Zdrenghea, Dumitru ; Tomoaia, Raluca ; Dădârlat-Pop, Alexandra ; Pop, Dana</creator><creatorcontrib>Frîngu, Florina ; Zdrenghea, Dumitru ; Tomoaia, Raluca ; Dădârlat-Pop, Alexandra ; Pop, Dana</creatorcontrib><description>•HF-biomarkers used in the general population are also suitable in patients with DM•sST2 levels are significantly correlated with NT-proBNP and hypocholesterolemia•Gal-3 sees the highest levels in subjects with DM and microvascular complications</description><identifier>ISSN: 0953-6205</identifier><identifier>EISSN: 1879-0828</identifier><identifier>DOI: 10.1016/j.ejim.2020.04.025</identifier><identifier>PMID: 32305288</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Biomarkers ; Diabetes Complications ; Diabetes Mellitus, Type 2 - complications ; Diabetic Angiopathies ; Heart Failure ; Humans</subject><ispartof>European journal of internal medicine, 2020-08, Vol.78, p.157-158</ispartof><rights>2020 European Federation of Internal Medicine</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c307t-8786977465ebb2b28a0c967d7fdba140509f9a767f81226ec6e396a6a2ad02183</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0953620520301394$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27903,27904,65309</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32305288$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Frîngu, Florina</creatorcontrib><creatorcontrib>Zdrenghea, Dumitru</creatorcontrib><creatorcontrib>Tomoaia, Raluca</creatorcontrib><creatorcontrib>Dădârlat-Pop, Alexandra</creatorcontrib><creatorcontrib>Pop, Dana</creatorcontrib><title>The Impact Of Diabetes Mellitus And Microvascular Complications On Heart Failure Biomarkers</title><title>European journal of internal medicine</title><addtitle>Eur J Intern Med</addtitle><description>•HF-biomarkers used in the general population are also suitable in patients with DM•sST2 levels are significantly correlated with NT-proBNP and hypocholesterolemia•Gal-3 sees the highest levels in subjects with DM and microvascular complications</description><subject>Biomarkers</subject><subject>Diabetes Complications</subject><subject>Diabetes Mellitus, Type 2 - complications</subject><subject>Diabetic Angiopathies</subject><subject>Heart Failure</subject><subject>Humans</subject><issn>0953-6205</issn><issn>1879-0828</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kEtP3DAUha2qVZlS_kAXlZfdJL2-SfyQ2MAABQk0G7piYTnOjeppHoOdjMS_J6OBLru6m-8c3fMx9k1ALkDIn9uctqHPERByKHPA6gNbCa1MBhr1R7YCUxWZRKhO2JeUtgBCARSf2UmBBVSo9Yo9Pf4hftfvnJ_4puVXwdU0UeIP1HVhmhO_GBr-EHwc9y75uXORr8d-1wXvpjAOiW8GfksuTvzGhW6OxC_D2Lv4l2L6yj61rkt09nZP2e-b68f1bXa_-XW3vrjPfAFqyrTS0ihVyorqGmvUDryRqlFtUztRQgWmNU5J1WqBKMlLKox00qFrAIUuTtmPY-8ujs8zpcn2IfllgBtonJPFwmApFZZmQfGILoNSitTaXQzLuy9WgD1ItVt7kGoPUi2UdpG6hL6_9c91T82_yLvFBTg_ArSs3AeKNvlAg6cmRPKTbcbwv_5Xse2Hdw</recordid><startdate>202008</startdate><enddate>202008</enddate><creator>Frîngu, Florina</creator><creator>Zdrenghea, Dumitru</creator><creator>Tomoaia, Raluca</creator><creator>Dădârlat-Pop, Alexandra</creator><creator>Pop, Dana</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>202008</creationdate><title>The Impact Of Diabetes Mellitus And Microvascular Complications On Heart Failure Biomarkers</title><author>Frîngu, Florina ; Zdrenghea, Dumitru ; Tomoaia, Raluca ; Dădârlat-Pop, Alexandra ; Pop, Dana</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c307t-8786977465ebb2b28a0c967d7fdba140509f9a767f81226ec6e396a6a2ad02183</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Biomarkers</topic><topic>Diabetes Complications</topic><topic>Diabetes Mellitus, Type 2 - complications</topic><topic>Diabetic Angiopathies</topic><topic>Heart Failure</topic><topic>Humans</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Frîngu, Florina</creatorcontrib><creatorcontrib>Zdrenghea, Dumitru</creatorcontrib><creatorcontrib>Tomoaia, Raluca</creatorcontrib><creatorcontrib>Dădârlat-Pop, Alexandra</creatorcontrib><creatorcontrib>Pop, Dana</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of internal medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Frîngu, Florina</au><au>Zdrenghea, Dumitru</au><au>Tomoaia, Raluca</au><au>Dădârlat-Pop, Alexandra</au><au>Pop, Dana</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The Impact Of Diabetes Mellitus And Microvascular Complications On Heart Failure Biomarkers</atitle><jtitle>European journal of internal medicine</jtitle><addtitle>Eur J Intern Med</addtitle><date>2020-08</date><risdate>2020</risdate><volume>78</volume><spage>157</spage><epage>158</epage><pages>157-158</pages><issn>0953-6205</issn><eissn>1879-0828</eissn><abstract>•HF-biomarkers used in the general population are also suitable in patients with DM•sST2 levels are significantly correlated with NT-proBNP and hypocholesterolemia•Gal-3 sees the highest levels in subjects with DM and microvascular complications</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>32305288</pmid><doi>10.1016/j.ejim.2020.04.025</doi><tpages>2</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0953-6205 |
| ispartof | European journal of internal medicine, 2020-08, Vol.78, p.157-158 |
| issn | 0953-6205 1879-0828 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2392467249 |
| source | MEDLINE; Elsevier ScienceDirect Journals |
| subjects | Biomarkers Diabetes Complications Diabetes Mellitus, Type 2 - complications Diabetic Angiopathies Heart Failure Humans |
| title | The Impact Of Diabetes Mellitus And Microvascular Complications On Heart Failure Biomarkers |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T06%3A20%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20Impact%20Of%20Diabetes%20Mellitus%20And%20Microvascular%20Complications%20On%20Heart%20Failure%20Biomarkers&rft.jtitle=European%20journal%20of%20internal%20medicine&rft.au=Fr%C3%AEngu,%20Florina&rft.date=2020-08&rft.volume=78&rft.spage=157&rft.epage=158&rft.pages=157-158&rft.issn=0953-6205&rft.eissn=1879-0828&rft_id=info:doi/10.1016/j.ejim.2020.04.025&rft_dat=%3Cproquest_cross%3E2392467249%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2392467249&rft_id=info:pmid/32305288&rft_els_id=S0953620520301394&rfr_iscdi=true |